11-93738138-C-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_024116.4(TAF1D):​c.430G>T​(p.Ala144Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000425 in 1,410,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000043 ( 0 hom. )

Consequence

TAF1D
NM_024116.4 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.539

Publications

2 publications found
Variant links:
Genes affected
TAF1D (HGNC:28759): (TATA-box binding protein associated factor, RNA polymerase I subunit D) TAF1D is a member of the SL1 complex, which includes TBP (MIM 600075) and TAF1A (MIM 604903), TAF1B (MIM 604904), and TAF1C (MIM 604905), and plays a role in RNA polymerase I transcription (Wang et al., 2004 [PubMed 15520167]; Gorski et al., 2007 [PubMed 17318177]).[supplied by OMIM, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.065695256).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAF1DNM_024116.4 linkc.430G>T p.Ala144Ser missense_variant Exon 3 of 6 ENST00000448108.7 NP_077021.1 Q9H5J8A0A024R3A9
TAF1DNR_146090.2 linkn.631G>T non_coding_transcript_exon_variant Exon 3 of 14
TAF1DNR_146091.2 linkn.631G>T non_coding_transcript_exon_variant Exon 3 of 14

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAF1DENST00000448108.7 linkc.430G>T p.Ala144Ser missense_variant Exon 3 of 6 5 NM_024116.4 ENSP00000410409.2 Q9H5J8

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000145
AC:
3
AN:
206772
AF XY:
0.00000885
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000130
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000425
AC:
6
AN:
1410364
Hom.:
0
Cov.:
31
AF XY:
0.00000286
AC XY:
2
AN XY:
700014
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30434
American (AMR)
AF:
0.00
AC:
0
AN:
29528
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23252
East Asian (EAS)
AF:
0.0000514
AC:
2
AN:
38892
South Asian (SAS)
AF:
0.0000388
AC:
3
AN:
77318
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51832
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5476
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1095662
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57970
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000165
AC:
2
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 03, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.430G>T (p.A144S) alteration is located in exon 3 (coding exon 2) of the TAF1D gene. This alteration results from a G to T substitution at nucleotide position 430, causing the alanine (A) at amino acid position 144 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
8.8
DANN
Benign
0.72
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.20
T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.066
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.54
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.48
N
REVEL
Benign
0.019
Sift
Benign
0.12
T
Sift4G
Benign
0.39
T
Polyphen
0.48
P
Vest4
0.12
MutPred
0.31
Gain of disorder (P = 0.0269);
MVP
0.099
MPC
0.095
ClinPred
0.026
T
GERP RS
-1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.097
gMVP
0.18
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200414618; hg19: chr11-93471304; API